Venture Capital

TaeWoong Medical USA's new FDA-cleared SPAXUS stent offers a safer, minimally invasive option for complex pancreatic and gallbladder drainage procedures.

Noema Pharma's investigational drug cendifensine not only cut hot flashes by 92% but also aided weight loss and mood, promising a new non-hormonal era.

At Knowledge 2026, ServiceNow partner inMorphis debuted a new framework and 30+ AI agents to solve AI implementation with a focus on trust and security.

International Business University's new Ottawa campus aims to fill critical talent gaps with specialized MBAs and key industry partnerships.

Medcura adds a Johnson & Johnson heavyweight to its board, aiming to disrupt the surgical hemostasis market with its FDA-designated breakthrough gel, LifeGel.

After 130 years, national construction leader The Boldt Group transitions to full employee ownership, securing its family legacy and empowering its workforce.

AI-native firm Norm Law adds veteran tax and fund formation counsel, deepening its tech-driven challenge to the traditional legal services model for investors.

From TikTok sensation to retail giant, KSECRET brings its potent retinal and black ginseng serum to Costco, signaling a new era for K-Beauty in America.

Diakonos Oncology's personalized therapy, DOC1021, reports impressive survival data in early trials for glioblastoma and pancreatic cancer.

A new partnership brings clinically-backed liver support to your daily smoothie, signaling a major shift in the functional beverage market.

A new study reveals a stark divide on what it means to be American, as AAPIs report rising anxiety and a profound disconnect from the general public.

A new partnership aims to accelerate data-driven innovation, tackle productivity gaps, and empower British manufacturers with advanced analytics.

This Gen Z startup's viral AI videos are moving education beyond simple answers, attracting millions of users and major enterprise interest.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

MPS smashes Q1 revenue records, fueled by a 98% surge in its AI data segment. The company now eyes a massive $6 billion capacity expansion.

Contineum Therapeutics reports encouraging early data for its non-opioid drug PIPE-791, offering a potential new weapon in the fight against chronic pain.

With a new CEO who helped build Liquid Death, A-GAME Beverages is betting his CPG playbook can turn the athlete-backed brand into a national powerhouse.

A new partnership aims to make powerful FPGA chips accessible to hobbyists and startups, potentially sparking a new wave of hardware innovation.

As Kodak prepares its Q1 2026 report, investors are watching to see if its pivot to advanced materials can sustain its recent market momentum.

A major expansion of a homegrown school meals program aims to nourish children and boost local economies, turning classrooms into hubs of community growth.